These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 3896040

  • 1. Therapy for late post infarction ventricular tachycardia.
    Somberg JC, Butler B, Torres V, Tepper D, Keren G, Siegel L, Jentzer J, Miura DS.
    Angiology; 1985 Mar; 36(3):181-90. PubMed ID: 3896040
    [Abstract] [Full Text] [Related]

  • 2. Lorcainide therapy for the high-risk patient post myocardial infarction.
    Somberg JC, Butler B, Torres V, Flowers D, Tepper D, Keefe D, Miura DS.
    Am J Cardiol; 1984 Aug 13; 54(4):37B-42B. PubMed ID: 6465045
    [Abstract] [Full Text] [Related]

  • 3. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC, Butler B, Flowers D, Tepper D, Maguire W, Willens H, Keren G, Miura D.
    Am J Cardiol; 1984 Aug 13; 54(4):49B-54B. PubMed ID: 6465047
    [Abstract] [Full Text] [Related]

  • 4. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study.
    Buxton AE, Marchlinski FE, Flores BT, Miller JM, Doherty JU, Josephson ME.
    Circulation; 1987 Jun 13; 75(6):1178-85. PubMed ID: 3568327
    [Abstract] [Full Text] [Related]

  • 5. Pacing termination of ventricular tachycardia: influence of antiarrhythmic-slowed ectopic rate.
    Keren G, Miura DS, Somberg JC.
    Am Heart J; 1984 Apr 13; 107(4):638-43. PubMed ID: 6702556
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Value of programmed ventricular stimulation in predicting sudden death and sustained ventricular tachycardia in survivors of acute myocardial infarction.
    Zoni-Berisso M, Molini D, Mela GS, Vecchio C.
    Am J Cardiol; 1996 Apr 01; 77(9):673-80. PubMed ID: 8651115
    [Abstract] [Full Text] [Related]

  • 8. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG, Martins JB, Wendt DJ, Constantin L, Hopson R, McCue ML.
    Am J Cardiol; 1988 May 01; 61(13):1012-7. PubMed ID: 3129926
    [Abstract] [Full Text] [Related]

  • 9. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV, Estes M, Heine DL, Griffith LS, Garan H, Ruskin JN, Reid PR.
    Am J Cardiol; 1985 Apr 01; 55(8):956-62. PubMed ID: 3984883
    [Abstract] [Full Text] [Related]

  • 10. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy.
    Poll DS, Marchlinski FE, Buxton AE, Doherty JU, Waxman HL, Josephson ME.
    Circulation; 1984 Sep 01; 70(3):451-6. PubMed ID: 6744550
    [Abstract] [Full Text] [Related]

  • 11. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M, Kasanuki H, Ohnishi S, Hosoda S.
    J Cardiol; 1996 Nov 01; 28(5):267-76. PubMed ID: 8953400
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide.
    Karagueuzian HS, Sugi K, Ohta M, Meesmann M, Ino T, Peter T, Mandel WJ.
    Am Heart J; 1986 Dec 01; 112(6):1173-83. PubMed ID: 3788764
    [Abstract] [Full Text] [Related]

  • 14. Value of electrophysiologic testing in patients with previous myocardial infarction and nonsustained ventricular tachycardia. Philadelphia Arrhythmia Group.
    Kowey PR, Waxman HL, Greenspon A, Greenberg R, Poll D, Kutalek S, Gessman L, Muenz L.
    Am J Cardiol; 1990 Mar 01; 65(9):594-8. PubMed ID: 2309629
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH.
    Am J Cardiol; 1988 Aug 25; 62(6):44D-55D. PubMed ID: 3136636
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC, Butler B, Flowers D, Keefe D, Torres V, Miura D.
    Am J Cardiol; 1984 Aug 13; 54(4):43B-48B. PubMed ID: 6465046
    [Abstract] [Full Text] [Related]

  • 17. Long-term lorcainide therapy in patients with ventricular tachycardia.
    Somberg J, Butler B, Flowers D, Keefe D, Torres V, Miura D.
    Am Heart J; 1985 Jan 13; 109(1):33-40. PubMed ID: 3966330
    [Abstract] [Full Text] [Related]

  • 18. Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia.
    Webb CR, Morganroth J, Senior S, Spielman SR, Greenspan AM, Horowitz LN.
    J Am Coll Cardiol; 1986 Jul 13; 8(1):214-20. PubMed ID: 3711519
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Are anti-arrhythmia agents superior to a beta blocker in treating life-threatening ventricular arrhythmias? Preliminary results of a controlled study].
    Steinbeck G, Andresen D, von Leitner ER.
    Z Kardiol; 1986 Jul 13; 75 Suppl 5():47-55. PubMed ID: 2435071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.